The sales for the March 2026 quarter moved down to Rs. 41.08 millions as compared to Rs. 52.20 millions during the year-ago period.The Net Loss for the quarter ended March 2026 is Rs. -89.82 millions as compared to Net Loss of Rs. -8.91 millions of corresponding quarter ended March 2025 Operating profit Margin for the quarter ended March 2026 further decreased to -84.67% as compared to -9.09% of corresponding quarter ended March 2025

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	41.08	52.20	-21.30	173.92	52.20	233.18	173.92	52.20	233.18
Other Income	4.34	6.49	-33.13	34.93	34.57	1.04	34.93	34.57	1.04
PBIDT	-84.67	-9.09	831.46	-51.75	12.20	-524.18	-51.75	12.20	-524.18
Interest	12.66	1.24	920.97	46.52	1.32	3424.24	46.52	1.32	3424.24
PBDT	-97.33	-10.33	842.21	-98.27	10.88	-1003.22	-98.27	10.88	-1003.22
Depreciation	4.34	0.99	338.38	6.79	1.27	434.65	6.79	1.27	434.65
PBT	-101.67	-11.32	798.14	-105.06	9.61	-1193.24	-105.06	9.61	-1193.24
TAX	-11.85	-2.41	391.70	-0.83	2.98	-127.85	-0.83	2.98	-127.85
Deferred Tax	-12.75	-2.75	363.64	-1.73	-2.76	-37.32	-1.73	-2.76	-37.32
PAT	-89.82	-8.91	908.08	-104.23	6.63	-1672.10	-104.23	6.63	-1672.10
Equity	654.52	638.02	2.59	654.52	638.02	2.59	654.52	638.02	2.59
PBIDTM(%)	-206.11	-17.41	1083.60	-29.76	23.37	-227.31	-29.76	23.37	-227.31

Fischer Medical Ventures Ltd.